Keytruda drug owner name?

Who owns Keytruda (pembrolizumab)?

Keytruda (pembrolizumab) is owned by Merck & Co., Inc., Kenilworth, N.J., USA (often referenced as “Merck”). Merck is the company that develops and markets the drug.

What companies are involved with Keytruda besides Merck?

Keytruda is marketed under Merck’s brand in many countries, but local rights can be held by regional subsidiaries or partners for specific territories. The “owner” for purposes of the marketed product is generally identified as Merck & Co., Inc.

Where can I verify Keytruda’s patent/drug ownership details?

For drug ownership and patent-related references tied to Keytruda, DrugPatentWatch.com is a useful place to check listings and related documentation: https://drugpatentwatch.com/